Skip to main content

Global Navigation

  • Other sites:
  • ECDC
  • European Antibiotic Awareness Day
  • ESCAIDE - Scientific conference
  • Eurosurveillance journal
  • EVIP - Vaccination portal
European Centre for Disease Prevention and Control

European Centre for Disease Prevention and Control

An agency of the European Union

Main Navigation

  • Home
  • All topics: A to Z

Secondary Navigation

  • Newsroom
  • Publications & data
  • Tools
  • About us

Search

Filter by:
Page 1 of 10 // 94 Results found

Publication

A scoping review of point-of-care testing devices for infectious disease surveillance, prevention and control

Technical report - 27 Apr 2022

This document provides the final report of a scoping review undertaken as part of a wider study on the ‘Assessment of point of care testing devices for infectious disease surveillance, prevention and control’ that was commissioned by ECDC and undertaken by RAND Europe between November 2019 and April 2020. 

A scoping review of point-of-care testing devices for infectious disease surveillance, prevention and control - EN - [PDF-3.55 MB]
  • Diagnostic test
  • EU/EEA
  • Microbiology

Publication

Assessment of point-of-care testing devices for infectious disease surveillance, prevention and control – a mapping exercise

Technical report - 27 Apr 2022

This document provides the final report of a mapping exercise undertaken as part of a wider study that was commissioned by ECDC and undertaken by RAND Europe between November 2019 and April 2020. 

Assessment of point-of-care testing devices for infectious disease surveillance, prevention and control – a mapping exercise - EN - [PDF-2.91 MB]
  • Diagnostic test
  • EU/EEA
  • Microbiology

Publication

Evaluation of the SARS-CoV-2 testing policy in Belgium from June to December 2021

Technical report - 14 Feb 2022

The aim of this report is to independently evaluate the Belgian SARS-CoV testing policy to support an optimal and sustainable testing policy for public health purposes.

Evaluation of the SARS-CoV-2 testing policy in Belgium from June to December 2021 - EN - [PDF-1.23 MB]
  • Belgium
  • Coronavirus
  • COVID-19
  • Diagnostic test
  • Prevention and control
  • Public health threat
  • SARS-CoV-2 variants
  • Scientific advice
  • Surveillance

Publication

Considerations for the use of antibody tests for SARS-CoV-2 – first update

Technical report - 10 Feb 2022

This report is the first update of a brief technical note that was developed at the request of the European Commission to inform the discussion on Digital Green Certificates to facilitate the safe and free movement of citizens within the EU during the COVID-19 pandemic.

Considerations for the use of antibody tests for SARS-CoV-2 – first update, 10 February 2022 - EN - [PDF-386.55 KB]
  • Coronavirus
  • COVID-19
  • Diagnostic test
  • Immunisation
  • Public health response
  • Public health threat

Publication

Options for the use of rapid antigen tests for COVID-19 in the EU/EEA - first update

Technical report - 26 Oct 2021

This document is the first update of the technical report ‘Options for the use of rapid antigen detection tests (RADTs) for COVID-19 in the EU/EEA’. It is intended to facilitate further discussions between Member States on the settings and purpose for which it is appropriate to use RADTs and summarises key considerations for their implementation. Reaching an agreement on settings and performance criteria will be critical for the success of EU/EEA-wide surveillance purposes and for measures related to cross-border travel.

Options for the use of rapid antigen detection tests for COVID-19 in the EU/EEA – first update - EN - [PDF-575.72 KB]
  • Coronavirus
  • COVID-19
  • Diagnostic test
  • EU/EEA
  • Public health threat
  • Scientific advice

Data

Testing rates per 100 000 inhabitants, updated 9 September 2021, week 35

Map - 9 Sep 2021

Maps in support of the Council Recommendation on a coordinated approach to travel measures in the EU.

  • Coronavirus
  • COVID-19
  • Diagnostic test
  • Public health threat
  • Surveillance

Publication

Considerations on the use of rapid antigen detection (including self-) tests for SARS-CoV-2 in occupational settings

Technical report - 6 May 2021

This document outlines the public health considerations for the use of rapid antigen detection tests (RADTs), including self-test RADTs to detect SARS-CoV-2 in individuals in occupational settings in the European Union/European Economic Area (EU/EEA), and provides information on the use of such tests in an occupational safety and health at work context.

Considerations on the use of rapid antigen detection (including self-) tests for SARS-CoV-2 in occupational settings - EN - [PDF-738.9 KB]
  • Coronavirus
  • COVID-19
  • Diagnostic test
  • EU/EEA
  • Prevention and control
  • Public health threat
  • Scientific advice

Data

Infographic: rapid antigen tests for SARS-CoV-2 in the workplace

Infographic - 6 May 2021

Joint ECDC - EU-OSHA infographic on the use of rapid antigen tests for SARS-CoV-2, the virus that causes COVID-19, in the workplace.

  • Coronavirus
  • COVID-19
  • Diagnostic test
  • EU/EEA
  • Prevention and control

Publication

Considerations for the use of saliva as sample material for COVID-19 testing

Technical report - 3 May 2021

This document outlines the use of saliva as a diagnostic sample for detecting SARS-CoV-2 infection, considering the advantages, limitations and uncertainties associated with the use of saliva as sample material.

Considerations for the use of saliva as sample material for COVID-19 testing - EN - [PDF-253.29 KB]
  • Community acquired infections
  • Coronavirus
  • COVID-19
  • Diagnostic test
  • Microbiology
  • Public health threat

Publication

Hepatitis B and C testing in the EU/EEA: progress in reaching the elimination targets

Technical report - 26 Mar 2021

This brief will present a snapshot of hepatitis B and C testing in the European Union/European Economic Area (EU/EEA), discussing progress made towards the European action plan 2020 testing target, focussing on key populations and settings for testing, barriers to testing, and testing policies.

Hepatitis B and C testing in the EU/EEA: progress in reaching the elimination targets - EN - [PDF-514.82 KB]
  • Diagnostic test
  • EU/EEA
  • Hepatitis B
  • Hepatitis C

Pagination

  • Current page 1
  • Page 2
  • Page 3
  • Page 4
  • Page 5
  • Page 6
  • Page 7
  • Page 8
  • Page 9
  • Next page ››
  • Last page Last »
  • About us

    • What we do
    • Who we are
    • Governance
  • Work with us

    • Vacancies
    • Fellowships
    • Traineeships
    • Procurement and grants
  • Contact ECDC

    • Visit us
    • ECDC press room
    • Social media
Log in to ECDC Extranet
Newsletter RSS

Follow us:

Facebook Twitter Youtube Linked In Vimeo Slide share

Footer Navigation

  • Legal notice
  • Copyright
  • Access to TESSy
  • Personal data protection
  • Language policy
  • Cookies
  • Accessibility
  • Sitemap
© European Centre for Disease Prevention and Control (ECDC) 2022
  • Other sites:
    • ECDC
    • European Antibiotic Awareness Day
    • ESCAIDE - Scientific conference
    • Eurosurveillance journal
    • EVIP - Vaccination portal
  • Search:
  • Home
  • All topics: A to Z
  • Newsroom
  • Publications & data
  • Tools
  • About us